Loading...
Tenshi Kaizen Private Limited — Loperamide Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #2 for Loperamide · $4.6M export value · DGFT Verified
Tenshi Kaizen Private Limited is the #2 Indian exporter of Loperamide with $4.6M in export value and 211 verified shipments. Tenshi Kaizen Private Limited holds a 6.1% market share in Loperamide exports across 8 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| ROMANIA | $992.1K | 37 | 29.7% |
| CANADA | $667.7K | 47 | 20.0% |
| GERMANY | $530.3K | 42 | 15.9% |
| UNITED KINGDOM | $438.2K | 32 | 13.1% |
| FRANCE | $282.2K | 24 | 8.5% |
| SPAIN | $163.0K | 5 | 4.9% |
| AUSTRALIA | $155.2K | 12 | 4.6% |
| POLAND | $108.8K | 12 | 3.3% |
Tenshi Kaizen Private Limited exports Loperamide to 8 countries. The largest destination is ROMANIA accounting for 29.7% of Tenshi Kaizen Private Limited's Loperamide shipments, followed by CANADA (20.0%) and GERMANY (15.9%). These destinations reflect Tenshi Kaizen Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| KLINGE PHARMA GMBH | GERMANY | $470.8K | 39 |
| S.C SANTAS.A., | ROMANIA | $447.8K | 14 |
| STRIDES PHARMA UK LTD | UNITED KINGDOM | $376.7K | 29 |
| M/S.JUNO OTC | CANADA | $300.2K | 17 |
| S.C SANTAS.A STR.CARPATILORNE.60, | ROMANIA | $189.5K | 7 |
India exported $23.2M worth of Loperamide through 3,985 shipments from 305 suppliers to 128 countries, serving 1,005 buyers globally. Tenshi Kaizen Private Limited contributes $4.6M to this total, accounting for 6.1% of India's Loperamide exports. Tenshi Kaizen Private Limited ships Loperamide to 8 countries through 28 buyers.
Tenshi Kaizen Private Limited's average Loperamide shipment value is $21.8K per consignment, based on 211 shipments totaling $4.6M. The largest destination is ROMANIA (29.7% of Tenshi Kaizen Private Limited's Loperamide exports).
Tenshi Kaizen Private Limited ranks #2 among 305 Indian Loperamide exporters with a 6.1% market share. The top 3 exporters are TENSHI KAIZEN PRIVATE LIMITED ($4.6M), RUBICON RESEARCH PRIVATE LIMITED ($2.4M), IPCA LABORATORIES LIMITED ($2.1M). Tenshi Kaizen Private Limited processed 211 shipments to 8 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOPERAMIDE HYDROCHLORIDE 2MG ORAL LYOPHILISATES SPUK-SIGMA 2X6S UK | $244.7K | 24 |
| LOPERAMIDE VIATRIS CONSEIL 2MG 2x6S | $200.0K | 4 |
| LOPERAMIDE VIATRIS CONSEIL 2 MG, 2 X 6 S | $105.2K | 3 |
| Loperamide Viatris Conseil 2mg, 2x6s-170 | $100.0K | 2 |
| LOPERAMIDE VIATRIAS CONSEIL 2MG 2x6S | $100.0K | 2 |
| Loperamide Viatris Conseil 2mg, 2x6s - B | $82.7K | 2 |
| LOPERAMIDE HCL ODT 2MG -EQUATE JUNO 20S | $81.2K | 4 |
| LOPERAMIDE SIGMA 2X6'S UK LOPERAMIDE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS 2 MG | $76.0K | 2 |
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12`S |
What Tenshi Kaizen Private Limited must comply with to export Loperamide to its top destination countries
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | TENSHI KAIZEN PRIVATE LIMITED ★ | $4.6M | 211 | 8 | $21.8K |
| 1 | RUBICON RESEARCH PRIVATE LIMITED | $2.4M | 48 | 1 | $50.0K |
| 4 | IPCA LABORATORIES LIMITED | $2.1M | 98 | 5 | $21.1K |
Tenshi Kaizen Private Limited ranks #2 among 305 Indian Loperamide exporters. Average shipment value of $21.8K compared to the market average of $76.1K. The closest competitors by value are RUBICON RESEARCH PRIVATE LIMITED and IPCA LABORATORIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 476 | 11.9% |
| SAHAR AIR | 446 | 11.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 436 | 10.9% |
| JNPT/ NHAVA SHEVA SEA | 246 | 6.2% |
| JNPT | 153 | 3.8% |
| BANGALORE ICD (INWFD6) | 150 | 3.8% |
| VIZAG SEA | 115 | 2.9% |
| HYDERABAD AIR | 105 | 2.6% |
Latest developments and market context
Detailed market intelligence for Loperamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Tenshi Kaizen Private Limited's Loperamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| FRANCE |
| $177.1K |
| 21 |
| JUNO OTC C/O INNOMAR | CANADA | $142.6K | 8 |
| LABORATORIOS CINFA S A | SPAIN | $133.2K | 4 |
| US PHARMACIA SP.ZO.O | POLAND | $108.8K | 12 |
| S C SANTAS A STR CARPATILORNR | ROMANIA | $108.3K | 3 |
Tenshi Kaizen Private Limited supplies Loperamide to 28 buyers globally. The largest buyer is KLINGE PHARMA GMBH (GERMANY), followed by S.C SANTAS.A., (ROMANIA) and STRIDES PHARMA UK LTD (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $75.1K |
| 4 |
| LOPERAMIDE HCL ODT 2MG LIFE BRAND 20S B | $72.9K | 3 |
Tenshi Kaizen Private Limited exports 133 distinct Loperamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOPERAMIDE HYDROCHLORIDE 2MG ORAL LYOPHILISATES SPUK-SIGMA 2 with 24 shipments worth $244.7K.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 128+ countries, 1,005+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Tenshi Kaizen Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Loperamide. For current shipment-level data, contact TransData Nexus.